INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Anthem Biosciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 544449	ISIN Demat INE0CZ201020	Book Value 44.05	NSE Symbol ANTHEM	Dividend Yield (%) 0	Market Cap (₹ Cr.) 42,480.18	P/E 83.86	EPS 9.02	Face Value 2

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023
Revenue From Operations	1,840.65	1,417.54	1,056.92
Sale of Products	308.80	309.73	1,056.92
Sale of Services	1,531.85	1,107.81	0.00
Income from Investment and Financial Services	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00
Other Operating Revenue	0.00	0.00	0.00
Less: Excise Duty / GST	0.00	0.00	0.00
Revenue From Operations - Net	1,840.65	1,417.54	1,056.92
Other Income	109.44	70.52	77.37
Total Revenue	1,950.09	1,488.06	1,134.30
Changes in Inventories	-86.70	-41.23	-9.01
Cost of Material Consumed	828.08	640.77	348.29
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00
Purchases of Stock-in-Trade	0.00	0.00	0.00
Employee Benefits	252.17	182.65	153.24
Total Other Expenses	158.10	130.47	135.35
Manufacturing / Operating Expenses	88.82	65.42	60.06
Administrative and Selling Expenses	56.00	54.67	60.66
Other Expenses	13.27	10.37	14.64
Finance Costs	9.09	9.14	6.75
Depreciation and Amortization	77.94	81.49	63.70
Total Expenses	1,238.67	1,003.29	698.32
Profit Before Exceptional Items and Tax	711.42	484.77	435.98
Exceptional Items Before Tax	0.00	0.00	61.80
Profit Before Extraordinary Items and Tax	711.42	484.77	497.78
Extraordinary Items Before Tax	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00
Profit Before Tax	711.42	484.77	497.78
Taxation	205.24	109.99	112.11
Current Tax	182.03	126.41	120.05
MAT Credit Entitlement	0.00	0.00	0.00
Deferred Tax	23.21	-16.42	-7.94
Other Tax	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00
Profit After Tax	506.19	374.78	385.67
Extraordinary Items After Tax	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00
Profit Attributable to Shareholders	506.19	374.78	385.67
Adjustments to Net Income	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	506.19	374.78	385.67
Earning Per Share - Basic	9.05	6.61	6.76
Earning Per Share - Diluted	9.01	6.61	6.76
Operation Profit before Depreciation	798.45	575.41	506.43
Operating Profit after Depreciation	720.51	493.92	442.73
Dividend Per Share	0.00	0.00	0.00
Dividend Percentage	0.00	0.00	0.00
Equity Dividend	0.00	0.00	0.00
Weighted Average Shares - Basic	55.91	56.70	57.05
Weighted Average Shares - Diluted	56.16	56.70	57.05